Back
Aclaris Therapeutics Vs. IGC Pharma Industry Stock Comparison
Sell
10
ACRS
Aclaris Therapeutics
Last Price:
1.22
Seasonality Move:
-1.77%
Buy
73
IGC
IGC Pharma
Last Price:
0.54
Seasonality Move:
2.47%
Sell
10
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.22. The Score for ACRS is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
73
IGC Pharma (IGC)
is a Buy
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.54. The Score for IGC is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- IGC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing selling pressure, which indicates risk of future bearish movement.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 47.53 | Sell |
| Chaikin Money Flow: | -897776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 1.28) | Sell |
| Bollinger Bands (100): | (1.1 - 1.28) | Buy |
IGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 57.21 | Buy |
| Chaikin Money Flow: | 426004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.58) | Buy |
| Bollinger Bands (100): | (0.26 - 0.48) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.28 | Sell |
| 20-day SMA: | 1.24 | Sell |
| 50-day SMA: | 1.23 | Sell |
| 200-day SMA: | 3.4 | Sell |
| 8-day EMA: | 1.28 | Sell |
| 20-day EMA: | 1.25 | Sell |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 3.45 | Sell |
IGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.51 | Buy |
| 20-day SMA: | 0.49 | Buy |
| 50-day SMA: | 0.45 | Buy |
| 200-day SMA: | 0.35 | Buy |
| 8-day EMA: | 0.51 | Buy |
| 20-day EMA: | 0.5 | Buy |
| 50-day EMA: | 0.45 | Buy |
| 200-day EMA: | 0.38 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.89 per share, and an increase next year of $0.03 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.06 per share.
Aclaris Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
IGC Pharma Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||